Form CORRESP - Correspondence:
SEC Accession No. 0001193125-17-197151
Filing Date
2017-06-07
Accepted
2017-06-07 17:08:56
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 7020
2 GRAPHIC g404725morganlewislogo2.jpg GRAPHIC 3924
  Complete submission text file 0001193125-17-197151.txt   13633
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)